Drug intelligence / Profile preview

euphrasia

Development stage
Phase 3
Administration
Oral, Topical, Ophthalmic
01

Overview

Euphrasia (commonly known as eyebright) is an herb traditionally used in European folk medicine for a variety of eye-related conditions such as conjunctivitis and eye irritation. The plant contains several bioactive compounds including flavonoids (luteolin and quercetin), iridoids (notably aucubin), phenolic acids, and essential oils. These constituents are believed to contribute to its anti-inflammatory, antioxidant, antimicrobial and antihistamine properties[1][2][3]. In traditional use—both herbal and homeopathic—euphrasia preparations have been applied topically or taken orally for symptoms like watery eyes from allergies or colds. However, there is insufficient scientific evidence supporting its efficacy for any medical condition[1][5][6]. Regulatory bodies such as the HMPC and Commission E do not recommend its use due to lack of proven benefit; some anthroposophic medicines in Germany still include it for non-purulent conjunctivitis[6]. Euphrasia is also used in homeopathy for various mucous membrane complaints[4][7].

Brand names
AufraiseAugentrostkrautCasse-LunettesEufrasiaEuphraiseHerbe d'EuphraiseLuminet
Other names
eyebrightEuphrasia officinalisEuphrasia rostkovianaEyewort

Beyond the preview

Go deeper on euphrasia.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on euphrasia.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call